These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 25254528

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bosentan for the treatment of portopulmonary hypertension.
    Tempe DK, Datt V, Datta D.
    Ann Card Anaesth; 2008; 11(2):139-40; author reply 140. PubMed ID: 18603763
    [No Abstract] [Full Text] [Related]

  • 5. The impact of treatment of portopulmonary hypertension on survival following liver transplantation.
    Ashfaq M, Chinnakotla S, Rogers L, Ausloos K, Saadeh S, Klintmalm GB, Ramsay M, Davis GL.
    Am J Transplant; 2007 May; 7(5):1258-64. PubMed ID: 17286619
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel use of sildenafil in the treatment of portopulmonary hypertension.
    Chua R, Keogh A, Miyashita M.
    J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension.
    Wang YW, Lin HC, Yang YY, Hou MC, Lee SD.
    J Gastroenterol; 2006 Jun; 41(6):593-7. PubMed ID: 16868809
    [Abstract] [Full Text] [Related]

  • 10. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
    Brancaccio G, Toscano A, Bevilacqua M, Di Chiara L, Parisi F.
    Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan.
    Halank M, Kolditz M, Miehlke S, Schiemanck S, Schmeisser A, Hoeffken G.
    Wien Med Wochenschr; 2005 Aug; 155(15-16):376-80. PubMed ID: 16160926
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension.
    Hoeper MM, Faulenbach C, Golpon H, Winkler J, Welte T, Niedermeyer J.
    Eur Respir J; 2004 Dec; 24(6):1007-10. PubMed ID: 15572546
    [Abstract] [Full Text] [Related]

  • 20. Portopulmonary hypertension associated with congenital absence of the portal vein treated with bosentan.
    Hino T, Hayashida A, Okahashi N, Wada N, Watanabe N, Obase K, Neishi Y, Kawamoto T, Okura H, Yoshida K.
    Intern Med; 2009 Dec; 48(8):597-600. PubMed ID: 19367055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.